selective androgen receptor degraders (Ipsen)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Nameselective androgen receptor degraders (Ipsen)

Drug Alias NameSARDs (Ipsen)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAndrogen Receptor modulators

TargetsAndrogen Receptor

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIpsen SA

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesIpsen SA

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

ATC CodeN/A